Jagsonpal Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.098x

Jagsonpal Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a cash flow conversion efficiency ratio of 0.098x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs246.75 Million ≈ $2.67 Million USD) by net assets (Rs2.53 Billion ≈ $27.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jagsonpal Pharmaceuticals Limited (2006–2026)

Cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2026. This chart illustrates how Jagsonpal Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View JAGSNPHARM stock price and chart for real-time trading data and today's change.

Jagsonpal Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Jagsonpal Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jagsonpal Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see Jagsonpal Pharmaceuticals Limited market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
ALEXANDRIA PANKKIIRILIIKE F:3ZL	N/A
EDAP TMS S.A. NASDAQ:FOCL	1.143x
CareRx Corp TO:CRRX	0.028x
Rico Auto Industries Limited NSE:RICOAUTO	0.190x
Sapura Energy Bhd KLSE:5218	-0.020x
Elanor Commercial Property Fund AU:ECF	0.066x
Sparebanken Ost OL:SPOG	0.022x
Bjorn Borg AB ST:BORG	0.364x

Annual Cash Flow Conversion Efficiency for Jagsonpal Pharmaceuticals Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2026. Review JAGSNPHARM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs2.76 Billion ≈ $29.87 Million	Rs468.12 Million ≈ $5.06 Million	0.170x	-26.45%
2025-03-31	Rs2.40 Billion ≈ $25.95 Million	Rs553.00 Million ≈ $5.98 Million	0.230x	+22.82%
2024-03-31	Rs1.87 Billion ≈ $20.27 Million	Rs351.66 Million ≈ $3.80 Million	0.188x	-36.09%
2023-03-31	Rs1.59 Billion ≈ $17.18 Million	Rs466.54 Million ≈ $5.05 Million	0.294x	+586.35%
2022-03-31	Rs1.31 Billion ≈ $14.15 Million	Rs55.98 Million ≈ $605.41K	0.043x	-81.52%
2021-03-31	Rs1.22 Billion ≈ $13.19 Million	Rs282.22 Million ≈ $3.05 Million	0.231x	+128.51%
2020-03-31	Rs1.11 Billion ≈ $12.01 Million	Rs112.47 Million ≈ $1.22 Million	0.101x	-65.75%
2019-03-31	Rs1.04 Billion ≈ $11.30 Million	Rs308.98 Million ≈ $3.34 Million	0.296x	+1940.07%
2018-03-31	Rs980.47 Million ≈ $10.60 Million	Rs-15.76 Million ≈ $-170.43K	-0.016x	+45.50%
2017-03-31	Rs1.10 Billion ≈ $11.89 Million	Rs-32.41 Million ≈ $-350.56K	-0.029x	-132.09%
2016-03-31	Rs983.64 Million ≈ $10.64 Million	Rs90.39 Million ≈ $977.48K	0.092x	+104.01%
2015-03-31	Rs954.26 Million ≈ $10.32 Million	Rs42.98 Million ≈ $464.81K	0.045x	-40.94%
2014-03-31	Rs985.89 Million ≈ $10.66 Million	Rs75.18 Million ≈ $813.08K	0.076x	-37.74%
2013-03-31	Rs983.71 Million ≈ $10.64 Million	Rs120.50 Million ≈ $1.30 Million	0.122x	+70.29%
2012-03-31	Rs984.69 Million ≈ $10.65 Million	Rs70.83 Million ≈ $766.00K	0.072x	+3.52%
2011-03-31	Rs929.14 Million ≈ $10.05 Million	Rs64.56 Million ≈ $698.20K	0.069x	+611.50%
2010-03-31	Rs875.70 Million ≈ $9.47 Million	Rs8.55 Million ≈ $92.49K	0.010x	-95.61%
2009-03-31	Rs801.68 Million ≈ $8.67 Million	Rs178.16 Million ≈ $1.93 Million	0.222x	+198.39%
2008-03-31	Rs750.34 Million ≈ $8.11 Million	Rs55.88 Million ≈ $604.33K	0.074x	+127.99%
2007-03-31	Rs724.98 Million ≈ $7.84 Million	Rs23.68 Million ≈ $256.11K	0.033x	+44.65%
2006-03-31	Rs702.35 Million ≈ $7.60 Million	Rs15.86 Million ≈ $171.53K	0.023x	--

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$154.16 Million

Rs14.25 Billion INR

Market Cap Rank

#17360 Global

#918 in India

Share Price

Rs216.21

Change (1 day)

-0.06%

52-Week Range

Rs161.07 - Rs243.97

All Time High

Rs761.20